Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
์ข
๋ชฉ ์ฝ๋ GRFS
ํ์ฌ ์ด๋ฆGrifols SA
์์ฅ์ผMay 17, 2006
CEOAbia (Jose Ignacio)
์ง์ ์23833
์ ํDepository Receipt
ํ๊ณ ์ฐ๋ ์ข
๋ฃMay 17
์ฃผ์Parque Empresarial Can Sant Joan
๋์SANT CUGAT DEL VALLES
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐSpain
์ฐํธ ๋ฒํธ08174
์ ํ34935710000
์น์ฌ์ดํธhttps://www.grifols.com/
์ข
๋ชฉ ์ฝ๋ GRFS
์์ฅ์ผMay 17, 2006
CEOAbia (Jose Ignacio)